• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级别胶质瘤的基因组特征分析:从肿瘤核心到瘤周脑区,历经胶质瘤衍生的肿瘤球。

Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres.

作者信息

Giambra Martina, Messuti Eleonora, Di Cristofori Andrea, Cavandoli Clarissa, Bruno Raffaele, Buonanno Raffaella, Marzorati Matilde, Zambuto Melissa, Rodriguez-Menendez Virginia, Redaelli Serena, Giussani Carlo, Bentivegna Angela

机构信息

School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy.

Neurosurgery Unit, Department of Neuroscience, S. Gerardo Hospital, 20900 Monza, Italy.

出版信息

Biology (Basel). 2021 Nov 9;10(11):1157. doi: 10.3390/biology10111157.

DOI:10.3390/biology10111157
PMID:34827152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615186/
Abstract

Glioblastoma is an extremely heterogeneous disease. Treatment failure and tumor recurrence primarily reflect the presence in the tumor core (TC) of the glioma stem cells (GSCs), and secondly the contribution, still to be defined, of the peritumoral brain zone (PBZ). Using the array-CGH platform, we deepened the genomic knowledge about the different components of GBM and we identified new specific biomarkers useful for new therapies. We firstly investigated the genomic profile of 20 TCs of GBM; then, for 14 cases and 7 cases, respectively, we compared these genomic profiles with those of the related GSC cultures and PBZ biopsies. The analysis on 20 TCs confirmed the intertumoral heterogeneity and a high percentage of copy number alterations (CNAs) in GBM canonical pathways. Comparing the genomic profiles of 14 TC-GSC pairs, we evidenced a robust similarity among the two samples of each patient. The shared imbalanced genes are related to the development and progression of cancer and in metabolic pathways, as shown by bioinformatic analysis using DAVID. Finally, the comparison between 7 TC-PBZ pairs leads to the identification of PBZ-unique alterations that require further investigation.

摘要

胶质母细胞瘤是一种极其异质性的疾病。治疗失败和肿瘤复发主要反映了胶质瘤干细胞(GSCs)在肿瘤核心(TC)中的存在,其次是瘤周脑区(PBZ)的作用,其作用仍有待确定。利用阵列比较基因组杂交(array-CGH)平台,我们深化了关于胶质母细胞瘤不同成分的基因组知识,并鉴定出可用于新疗法的新的特异性生物标志物。我们首先研究了20个胶质母细胞瘤肿瘤核心的基因组图谱;然后,分别针对14例和7例病例,将这些基因组图谱与相关的胶质瘤干细胞培养物和瘤周脑区活检组织的图谱进行了比较。对20个肿瘤核心的分析证实了肿瘤间的异质性以及胶质母细胞瘤经典通路中高比例的拷贝数改变(CNAs)。比较14对肿瘤核心-胶质瘤干细胞的基因组图谱,我们发现每个患者的两个样本之间存在很强的相似性。如使用DAVID进行的生物信息学分析所示,共享的失衡基因与癌症的发生发展以及代谢途径有关。最后,7对肿瘤核心-瘤周脑区的比较导致鉴定出需要进一步研究的瘤周脑区独特改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65a/8615186/0ff95fed49ad/biology-10-01157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65a/8615186/0a0f8481327d/biology-10-01157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65a/8615186/0ff95fed49ad/biology-10-01157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65a/8615186/0a0f8481327d/biology-10-01157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c65a/8615186/0ff95fed49ad/biology-10-01157-g002.jpg

相似文献

1
Characterizing the Genomic Profile in High-Grade Gliomas: From Tumor Core to Peritumoral Brain Zone, Passing through Glioma-Derived Tumorspheres.高级别胶质瘤的基因组特征分析:从肿瘤核心到瘤周脑区,历经胶质瘤衍生的肿瘤球。
Biology (Basel). 2021 Nov 9;10(11):1157. doi: 10.3390/biology10111157.
2
Differential gene expression in peritumoral brain zone of glioblastoma: role of SERPINA3 in promoting invasion, stemness and radioresistance of glioma cells and association with poor patient prognosis and recurrence.胶质母细胞瘤瘤周脑区差异基因表达:SERPINA3 在促进胶质瘤细胞侵袭、干性和放射抵抗中的作用及其与患者不良预后和复发的关系。
J Neurooncol. 2021 Mar;152(1):55-65. doi: 10.1007/s11060-020-03685-4. Epub 2021 Jan 3.
3
Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.胶质母细胞瘤瘤周脑区特征:多学科分析
J Neurooncol. 2015 Mar;122(1):53-61. doi: 10.1007/s11060-014-1695-8. Epub 2015 Jan 6.
4
The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity.人类胶质母细胞瘤及匹配的原发性癌症干细胞的基因图谱揭示了肿瘤内的相似性和肿瘤间的异质性。
Stem Cells Int. 2019 Mar 7;2019:2617030. doi: 10.1155/2019/2617030. eCollection 2019.
5
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.关于胶质母细胞瘤瘤周微环境的当前知识
Cancers (Basel). 2023 Nov 17;15(22):5460. doi: 10.3390/cancers15225460.
6
Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.白藜芦醇靶向作用于胶质母细胞瘤和胶质母细胞瘤干细胞中的 AKT 和 p53 以抑制生长和浸润。
J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.
7
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines.描绘神经胶质瘤干细胞系的细胞遗传学和表观基因组景观。
PLoS One. 2013;8(2):e57462. doi: 10.1371/journal.pone.0057462. Epub 2013 Feb 28.
8
Glioblastoma Primary Cells Retain the Most Copy Number Alterations That Predict Poor Survival in Glioma Patients.胶质母细胞瘤原代细胞保留了最多的拷贝数改变,这些改变预示着胶质瘤患者的生存预后不良。
Front Oncol. 2021 Apr 26;11:621432. doi: 10.3389/fonc.2021.621432. eCollection 2021.
9
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.在神经胶质瘤干细胞中维持原发性肿瘤表型和基因型。
Neuro Oncol. 2012 Feb;14(2):132-44. doi: 10.1093/neuonc/nor195. Epub 2011 Nov 7.
10
The peritumoral brain zone in glioblastoma: where we are and where we are going.胶质母细胞瘤的瘤周脑区:我们的现状与未来展望。
J Neurosci Res. 2023 Feb;101(2):199-216. doi: 10.1002/jnr.25134. Epub 2022 Oct 27.

引用本文的文献

1
Pericytes change function depending on glioblastoma vicinity: emphasis on immune regulation.周细胞根据胶质母细胞瘤的位置改变功能:着重于免疫调节。
Mol Oncol. 2025 Sep;19(9):2491-2514. doi: 10.1002/1878-0261.70095. Epub 2025 Jul 17.
2
Recapitulating Glioma Stem Cell Niches Using 3D Spheroid Models for Glioblastoma Research.利用 3D 球体模型重现神经胶质瘤干细胞龛用于神经胶质瘤研究。
Biosensors (Basel). 2024 Nov 7;14(11):539. doi: 10.3390/bios14110539.
3
Peritumoral Brain Zone in Astrocytoma: Morphology, Molecular Aspects, and Clinical Manifestations (Review).

本文引用的文献

1
Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance.多形性胶质母细胞瘤(GBM):当前治疗方法及耐药机制概述
Pharmacol Res. 2021 Sep;171:105780. doi: 10.1016/j.phrs.2021.105780. Epub 2021 Jul 21.
2
A Novel Classification of Glioma Subgroup, Which Is Highly Correlated With the Clinical Characteristics and Tumor Tissue Characteristics, Based on the Expression Levels of Gβ and Gγ Genes.基于Gβ和Gγ基因表达水平的一种与临床特征和肿瘤组织特征高度相关的胶质瘤亚组新分类。
Front Oncol. 2021 Jun 18;11:685823. doi: 10.3389/fonc.2021.685823. eCollection 2021.
3
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
脑胶质瘤瘤周区:形态学、分子学方面和临床表现(综述)。
Sovrem Tekhnologii Med. 2024;16(2):79-88. doi: 10.17691/stm2024.16.2.08. Epub 2024 Apr 27.
4
Multiparametric simultaneous hybrid F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging (F-FDG PET/MRI) incorporating intratumoral and peritumoral regions for grading of glioma.多参数同步混合F-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像(F-FDG PET/MRI)纳入肿瘤内和肿瘤周围区域用于胶质瘤分级
Quant Imaging Med Surg. 2024 Aug 1;14(8):5665-5681. doi: 10.21037/qims-24-280. Epub 2024 Jun 11.
5
Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.胶质母细胞瘤瘤周脑区:生物学、临床和力学特征。
Front Immunol. 2024 Feb 29;15:1347877. doi: 10.3389/fimmu.2024.1347877. eCollection 2024.
6
Vacuolar Proton-Translocating ATPase May Take Part in the Drug Resistance Phenotype of Glioma Stem Cells.液泡质子转运ATP酶可能参与胶质瘤干细胞的耐药表型。
Int J Mol Sci. 2024 Feb 27;25(5):2743. doi: 10.3390/ijms25052743.
7
Current Knowledge about the Peritumoral Microenvironment in Glioblastoma.关于胶质母细胞瘤瘤周微环境的当前知识
Cancers (Basel). 2023 Nov 17;15(22):5460. doi: 10.3390/cancers15225460.
8
AhRR and PPP1R3C: Potential Prognostic Biomarkers for Serous Ovarian Cancer.AhRR 和 PPP1R3C:浆液性卵巢癌的潜在预后生物标志物。
Int J Mol Sci. 2023 Jul 14;24(14):11455. doi: 10.3390/ijms241411455.
9
Advances in Immunotherapy and Innovative Therapeutic Approaches for Cancer Treatment: Editorial to the Special Issue "State-of-the-Art Molecular Oncology in Italy".免疫疗法的进展和癌症治疗的创新治疗方法:特刊“意大利最新分子肿瘤学”的社论。
Int J Mol Sci. 2023 May 18;24(10):8929. doi: 10.3390/ijms24108929.
10
Insights into the Peritumoural Brain Zone of Glioblastoma: and May Be Potential Drivers of Malignancy.脑胶质母细胞瘤瘤周脑区的研究进展:血管生成拟态和可能的恶性驱动因素。
Int J Mol Sci. 2023 Feb 2;24(3):2835. doi: 10.3390/ijms24032835.
2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
4
Genomic and Epigenomic Profile of Uterine Smooth Muscle Tumors of Uncertain Malignant Potential (STUMPs) Revealed Similarities and Differences with Leiomyomas and Leiomyosarcomas.具有不确定恶性潜能的子宫平滑肌肿瘤(STUMPs)的基因组和表观基因组特征揭示了其与平滑肌瘤和平滑肌肉瘤的异同。
Int J Mol Sci. 2021 Feb 4;22(4):1580. doi: 10.3390/ijms22041580.
5
EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.EGFR/SRC/ERK 稳定的 YTHDF2 促进脑胶质瘤的胆固醇失调和侵袭性生长。
Nat Commun. 2021 Jan 8;12(1):177. doi: 10.1038/s41467-020-20379-7.
6
Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.抑制 Gli2 可抑制源自从头建立的小鼠脑癌模型的脑肿瘤干细胞的致瘤性。
Cancer Gene Ther. 2021 Dec;28(12):1339-1352. doi: 10.1038/s41417-020-00282-5. Epub 2021 Jan 7.
7
Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression.铁死亡相关基因特征预测胶质瘤细胞死亡和胶质瘤患者病情进展。
Front Cell Dev Biol. 2020 Jul 9;8:538. doi: 10.3389/fcell.2020.00538. eCollection 2020.
8
Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma.缺氧诱导铁蛋白轻链(FTL)促进了胶质瘤上皮间质转化和化疗耐药性。
J Exp Clin Cancer Res. 2020 Jul 16;39(1):137. doi: 10.1186/s13046-020-01641-8.
9
A Neural Network Approach to Identify the Peritumoral Invasive Areas in Glioblastoma Patients by Using MR Radiomics.一种基于神经网络的方法,通过使用磁共振放射组学来识别胶质母细胞瘤患者的瘤周侵袭区。
Sci Rep. 2020 Jun 16;10(1):9748. doi: 10.1038/s41598-020-66691-6.
10
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series.用于复发性胶质母细胞瘤和进展性间变性胶质瘤前瞻性治疗的癌症干细胞化疗分析:单机构病例系列
Transl Oncol. 2020 Apr;13(4):100755. doi: 10.1016/j.tranon.2020.100755. Epub 2020 Mar 17.